Natural Product: NPC44682

Natural Product IDNPC44682
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
Albinoside Iii
IUPAC Name n.a.
Synonyms Albinoside III
Synthetic Gene Cluster n.a.
ChEMBL Identifier CHEMBL2146620
PubChem CID 71451029
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0003918] Saccharolipids

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey HUCKMCHVBAWQIA-DGBHNKMOSA-N
Standard InCHI InChI=1S/C56H92O25/c1-10-13-19-22-32-23-20-17-15-14-16-18-21-24-34(57)76-45-39(62)33(25-69-53-48(80-52-43(66)40(63)35(58)28(6)70-52)44(38(61)31(9)71-53)77-50(67)26(4)11-2)75-56(79-47-42(65)37(60)29(7)72-54(47)74-32)49(45)81-55-46(78-51(68)27(5)12-3)41(64)36(59)30(8)73-55/h11-12,28-33,35-49,52-56,58-66H,10,13-25H2,1-9H3/b26-11+,27-12+/t28-,29+,30-,31+,32-,33+,35-,36-,37+,38+,39+,40+,41+,42-,43+,44-,45-,46+,47+,48+,49+,52-,53+,54-,55-,56-/m0/s1
SMILES CCCCC[C@H]1CCCCCCCCCC(=O)O[C@H]2[C@@H]([C@@H](CO[C@H]3[C@@H]([C@H]([C@@H]([C@@H](C)O3)O)OC(=O)/C(=C/C)/C)O[C@H]3[C@@H]([C@@H]([C@H]([C@H](C)O3)O)O)O)O[C@H]([C@@H]2O[C@H]2[C@@H]([C@@H]([C@H]([C@H](C)O2)O)O)OC(=O)/C(=C/C)/C)O[C@@H]2[C@H]([C@@H]([C@@H](C)O[C@H]2O1)O)O)O

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   1164.59 Volume:   1132.366
?
Van der Waals volume.
Dense:   1.028 LogP:   2.688
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   2.977
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -3.518
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   17.0 Rigid Bonds:   51.0
TPSA:   353.27
?
Topological Polar Surface Area.
H-Bond Acceptor:   25.0
H-Bond Donor:   9.0 Rings:   6.0
Heavy Atoms:   25.0

MedChem Properties

QED Drug-Likeness Score:   0.048 GASA:   1.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   2.87 Fsp3:   0.875
MCE-18:   130.667
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Accepted
Pfizer Rule:   Rejected GSK Rule:   Accepted
Golden Triangle Rule:   Accepted BMS Rule:   1
Chelating Alert:   0 PAINS Alert:   0
Colloidal aggregators:   0.972 Fluc inhibitor:   0.359
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.003
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.003
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.518 Promiscuous compounds:   0.098

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -5.913 MDCK Permeability:   -4.958
Pgp-inhibitor:   0.0 Pgp-substrate:   0.95
PAMPA:   1.0
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.021
20% Bioavailability (F20%):   0.007 30% Bioavailability (F30%):   0.814
50% Bioavailability (F50%):   0.992

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.0 MRP1:   0.919
Plasma Protein Binding (PPB):   77.159% Volume Distribution (VD):   -0.367
Fu: 13.611%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   0.999
OATP1B3 inhibitor:   1.0 BCRP inhibitor:   0.0
BSEP inhibitor:   0.001

ADMET: Metabolism

CYP1A2-inhibitor:   0.0 CYP1A2-substrate:   0.0
CYP2C19-inhibitor:   0.0 CYP2C19-substrate:   0.0
CYP2C9-inhibitor:   0.0 CYP2C9-substrate:   0.0
CYP2D6-inhibitor:   0.0 CYP2D6-substrate:   0.001
CYP3A4-inhibitor:   0.0 CYP3A4-substrate:   1.0
CYP2B6-substrate:   0.0 CYP2C8-inhibitor:   0.867
HLM stability:   0.93
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  0.405 Half-life (T1/2):  3.487

ADMET: Toxicity

hERG Blockers:  0.012 hERG Blockers (10um):  0.225
Human Hepatotoxicity (H-HT):  0.357 Drug-induced Liver Injury (DILI):  0.989
AMES Toxicity:  0.615 Rat Oral Acute Toxicity:  0.001
Maximum Recommended Daily Dose:  0.004 Skin Sensitization:  1.0
Carcinogencity:  0.0 Eye Corrosion:  0.0
Eye Irritation:  0.002 Respiratory Toxicity:  0.0
Drug-induced Neurotoxicity:  0.0 Ototoxicity:  0.999
Hematotoxicity:  0.318 Drug-induced Nephrotoxicity:  0.96
Genotoxicity:  0.0 RPMI-8226 Immunitoxicity:  0.6
A549 Cytotoxicity:  0.954 Hek293 Cytotoxicity:  0.303
BCF:   0.418
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   3.285
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   5.126
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   4.092
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO13214 Ipomoea alba Species Convolvulaceae Eukaryota seeds n.a. n.a. PMID[22924480]
NPO13214 Ipomoea alba Species Convolvulaceae Eukaryota Seeds n.a. n.a. PMID[28006904]
NPO13214 Ipomoea alba Species Convolvulaceae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO13214 Ipomoea alba Species Convolvulaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT83 Cell line MCF7 Homo sapiens IC50 > 20.0 ug.mL-1 PMID[22924480]
NPT2 Others Unspecified n.a. FC > 1687.5 n.a. PMID[22924480]
NPT2 Others Unspecified n.a. FC > 2140.6 n.a. PMID[22924480]
NPT2 Others Unspecified n.a. FC > 73.4 n.a. PMID[22924480]

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC44682 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
0.6739 Remote Similarity NPC269318
0.6667 Remote Similarity NPC479056
0.6452 Remote Similarity NPC163409
0.6333 Remote Similarity NPC479061
0.6322 Remote Similarity NPC477349
0.6264 Remote Similarity NPC479060
0.6047 Remote Similarity NPC475425
0.5978 Remote Similarity NPC146992
0.5978 Remote Similarity NPC85759
0.5914 Remote Similarity NPC479058
0.5914 Remote Similarity NPC173328
0.5895 Remote Similarity NPC238056
0.5851 Remote Similarity NPC294748
0.5833 Remote Similarity NPC479057
0.5816 Remote Similarity NPC475164
0.5773 Remote Similarity NPC475525
0.5773 Remote Similarity NPC475540
0.5761 Remote Similarity NPC158302
0.5714 Remote Similarity NPC476066
0.5684 Remote Similarity NPC186992
0.5682 Remote Similarity NPC146380
0.5657 Remote Similarity NPC478728
0.5652 Remote Similarity NPC89843
0.5638 Remote Similarity NPC478722
0.5636 Remote Similarity NPC472352
0.56 Remote Similarity NPC473605
0.56 Remote Similarity NPC475375
0.5591 Remote Similarity NPC479059
0.5568 Remote Similarity NPC477350
0.5464 Remote Similarity NPC238264
0.5464 Remote Similarity NPC477345
0.5435 Remote Similarity NPC22742
0.5435 Remote Similarity NPC113745
0.5435 Remote Similarity NPC477346
0.5435 Remote Similarity NPC477320
0.5435 Remote Similarity NPC477323
0.5435 Remote Similarity NPC477325
0.5435 Remote Similarity NPC609436
0.5408 Remote Similarity NPC169345
0.5408 Remote Similarity NPC477317
0.5408 Remote Similarity NPC477318
0.5385 Remote Similarity NPC281563
0.5385 Remote Similarity NPC477329
0.5376 Remote Similarity NPC604005
0.5376 Remote Similarity NPC605014
0.5361 Remote Similarity NPC119583
0.5341 Remote Similarity NPC478729
0.5306 Remote Similarity NPC483170
0.5275 Remote Similarity NPC477330
0.5258 Remote Similarity NPC477319
0.5253 Remote Similarity NPC115013
0.5208 Remote Similarity NPC109887
0.5204 Remote Similarity NPC143421
0.5204 Remote Similarity NPC307400
0.5204 Remote Similarity NPC472204
0.5204 Remote Similarity NPC27289
0.5192 Remote Similarity NPC475241
0.5169 Remote Similarity NPC606819
0.5155 Remote Similarity NPC267592
0.5155 Remote Similarity NPC60849
0.5152 Remote Similarity NPC476087
0.5152 Remote Similarity NPC475667
0.5109 Remote Similarity NPC477328
0.5104 Remote Similarity NPC600446
0.5104 Remote Similarity NPC605013
0.51 Remote Similarity NPC290012
0.51 Remote Similarity NPC478732
0.5051 Remote Similarity NPC478730
0.505 Remote Similarity NPC475270
0.505 Remote Similarity NPC475327

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC44682 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
NPD

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data